SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013047
Filing Date
2022-05-12
Accepted
2022-05-12 16:21:42
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 753614
2 ex10-1.htm EX-10.1 729899
3 ex31-1.htm EX-31.1 13064
4 ex31-2.htm EX-31.2 13037
5 ex32-1.htm EX-32.1 9336
  Complete submission text file 0001493152-22-013047.txt   5509647

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE eton-20220331.xsd EX-101.SCH 38091
7 XBRL CALCULATION FILE eton-20220331_cal.xml EX-101.CAL 47137
8 XBRL DEFINITION FILE eton-20220331_def.xml EX-101.DEF 191647
9 XBRL LABEL FILE eton-20220331_lab.xml EX-101.LAB 357729
10 XBRL PRESENTATION FILE eton-20220331_pre.xml EX-101.PRE 268482
53 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 604288
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 22918148
SIC: 2834 Pharmaceutical Preparations